@article{JTD9179,
author = {David Grimaldi and Eduardo Wilfrido Goicoechea Turcott and Fabio Silvio Taccone},
title = {IL-1 receptor antagonist in sepsis: new findings with old data?},
journal = {Journal of Thoracic Disease},
volume = {8},
number = {9},
year = {2016},
keywords = {},
abstract = {In a recent issue of Critical Care Medicine, Shakoory et al. reported the potential benefits of IL-1 receptor antagonist (IL-1 RA, anakinra) administration in the treatment of severe sepsis and septic shock when associated with hepatic dysfunction and coagulopathy (1). This study is an ancillary sub-analysis of a negative randomized clinical trial (RCT), which evaluated the effect of IL-1 RA in the larger population and published almost two decades ago (2).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/9179}
}